Document Detail


Ketoconazole treatment of nail infection in chronic mucocutaneous candidiasis.
MedLine Citation:
PMID:  6316890     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic mucocutaneous candidiasis is an immunodeficiency disorder which has significant morbidity due to mucous membrane, skin and nail infection. Attempts at reconstitution of immunological abnormalities have had only limited success. Ketoconazole is a newly available oral antifungal agent with activity against candida species. Prolonged administration of ketoconazole to four children with chronic mucocutaneous candidiasis caused marked improvement at infected sites. Resolution of nail infections took up to 12 months.
Authors:
D M Roberton; C S Hosking
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Australian paediatric journal     Volume:  19     ISSN:  0004-993X     ISO Abbreviation:  Aust Paediatr J     Publication Date:  1983 Sep 
Date Detail:
Created Date:  1984-01-27     Completed Date:  1984-01-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  15420340R     Medline TA:  Aust Paediatr J     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  178-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Candidiasis / complications*
Candidiasis, Chronic Mucocutaneous / complications*,  drug therapy
Child
Child, Preschool
Female
Humans
Infant
Ketoconazole / therapeutic use*
Male
Nail Diseases / drug therapy*,  etiology
Chemical
Reg. No./Substance:
65277-42-1/Ketoconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Benign neoplasms of the larynx. A 10-year review of 38 patients.
Next Document:  The pathogenesis of infectious bursal disease: serologic, histopathologic, and clinical chemical obs...